CAS NO: | 51762-05-1 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Cefroxadine (CGP 9000) is an orally activecephalosporinantibiotic. Cefroxadine is more effective than cephalexin againstEscherichia coliandKlebsiella pneumoniaewithMICvalues of 3.13 and 1.56 μg/mL respectively with a concentration of 106μg/mL. Cefroxadine can be used for the research ofinfection[1]. | ||||||||
IC50& Target |
| ||||||||
体外研究 (In Vitro) | Cefroxadine (106-108μg/mL; overnight) shows antibacterial activities againstS. aureus,E. coli,S. typhi,S. paratyphi,S. schottmuelleri,K. apneumoniaeandP. mirabiliswith MIC values of 1.56, 3.31, 1.56, 1.56, 1.56, 1.56 and 6.25 μg/mL respectively with a concentration of 106μg/mL[1]. Cefroxadine (104-108μg/mL; overnight) shows antibacterial activities against 100E. colistrains with MIC50and MIC75values of 4.8-11.5 μg/mL and 6-20 μg/mL, respectively[1]. | ||||||||
体内研究 (In Vivo) | Cefroxadine (0-30 mg/kg; p.o. 0 and 3 h after infection) shows a better effect than cephalexin in vivo[1].
| ||||||||
分子量 | 365.40 | ||||||||
Formula | C16H19N3O5S | ||||||||
CAS 号 | 51762-05-1 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |